(Online Herald News — March 6, 2017) – Today, cervical cancer is recognized to be one of the most common types of cancers. It has been analyzed, worldwide; that it is mainly the third most common cancer among women and the second most frequent cause of cancer-related death, accounting for nearly 300,000 deaths annually. According to a recent study, which has been published to the mega-repository of Market Research Hub (MRH), clearly states that the global cervical cancer diagnostic tests market witnessed to acquire uppermost growth over the forecast period due to increasing percentage of HPV infected female population across the globe. This study is titled as “Global Cervical Cancer Diagnostic Tests Market Research Report 2017” which delivers comprehensive information about the market, by analyzing some of the key regions, including North America, China, India, Europe, Southeast Asia and Japan.
Request for Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1001271
Primarily, this research report provides a detailed analysis of the global cervical cancer diagnostic tests market and to understand the several driving factors for the growth of the market. The market overview section analyzes market dynamics and trends such as drivers, restraints and opportunities that can influence the current landscape and future status of the market.
Cervical cancer occurs when abnormal cells on the cervix (lower part of the uterus that opens into the vagina) grow out of control and turn into cancerous tumors. Mostly, all the cases of cervical cancer are caused due to a virus called Human Papilloma Virus, or HPV. According to the Centers for Disease Control and Prevention (CDC), 6 million people in the U.S. get infected by HPV each year.
Moreover, the report has segmented the global cervical cancer diagnostics tests market by test types and application. On the basis of test type, it mainly includes:
- HPV Testing
- Pap Smear Tests
- Colposcopy and others
With the growing number of cervical cancer diagnostic tests including Pap smear tests, HPV testing and colposcopy for initial detection, the demand of such market is defined as highly competitive with high growth rate. Also, increasing attentiveness about the screening and treatment of cervical cancer is expected to increase the growth of the market in the next few years.
By application, it can be classified into Cervical Cancer Diagnostic, Physical examination and others. For each regional, type and application segment; the report aims to provide the details of consumption, production, price, import/export, revenue, market share and growth rate for the forecast period of 2017-2022.
Moreover, the report covers detailed competitive outlook of the key player’s operating in the global market, such as
- Abbott Laboratories
- Roche Diagnostics
- OncoHealth Corp
- Guided Therapeutics
- Quest Diagnostics
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
90 State Street,
Albany, NY 12207,
Toll Free: 866-997-4948 (US-Canada)
Follow Us on: